Last updated on October 2008

A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL


Brief description of study

A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL

Detailed Study Description

The feasibility will be evaluated in terms of complete remission rate, duration of complete remission, disease-free survival, overall survival, and toxicities.

Clinical Study Identifier: NCT00774332

Find a site near you

Start Over

Asan Medical Center

Seoul, Korea, Republic of
  Connect »